Trial Profile
STANDARD VERSUS TAILORED ANTI-PLATELET THERAPY IN ACS PATIENTS UNDERGOING PERCUTANEOUS CORONARY ANGIOPLASTY
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Aug 2015
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary)
- Indications Acute coronary syndromes; Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms STAT
- 07 Jun 2011 New trial record